Febuxostat is superior to traditional urate-lowering agents in reducing the progression of kidney function in chronic kidney disease patients
Weng, Shuo-Chun, Tarng, Der-Cherng, Chen, Yu-Chi, Wu, Ming-Ju, Schumacher, UdoVolume:
3
Language:
english
Journal:
Cogent Medicine
DOI:
10.1080/2331205x.2016.1213215
Date:
December, 2016
File:
PDF, 1.46 MB
english, 2016